Volume 10, Number 6—June 2004
Dispatch
Antibacterial Resistance, Wayampis Amerindians, French Guyana
Karine Grenet*, Didier Guillemot†, Vincent Jarlier‡, Brigitte Moreau§, Stéphane Dubourdieu*, Laurent Boyer*, Laurence Armand-Lefevre*, Pierre Bau*, and Antoine Andremont*
Table 1
Antibacterial exposure in 388 Wayampi American Indians from three villages in southern French Guyana during the year preceding the studya
| Antibacterial agents | Frequency of antibacterial exposure in (%) |
||||
|---|---|---|---|---|---|
| TS (n = 85) | YP (n = 55) | Z (n = 248) | Total (n = 388) | p valueb | |
| Aminopenicillins |
5.9 |
14.6 |
23.8 |
18.6 |
0.007 |
| Metronidazole |
16.5 |
30.9 |
32.3 |
28.6 |
0.15 |
| Macrolides |
8.2 |
1.8 |
11.3 |
9.3 |
0.2 |
| Other |
5.8 |
7.3 |
8.9 |
8.0 |
0.7 |
| Overall | 36.5 | 54.6 | 76.2 | 64.4 | 0.007 |
aFrequency of antibacterial exposure was calculated by dividing the number of all antibacterial courses during the year preceding the study by the number of persons in each village.
bAnalysis of variance (ANOVA).
Page created: February 22, 2011
Page updated: February 22, 2011
Page reviewed: February 22, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.